These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transgenic animals as models of neurodegenerative diseases in humans. Theuring F; Thunecke M; Kosciessa U; Turner JD Trends Biotechnol; 1997 Aug; 15(8):320-5. PubMed ID: 9263480 [TBL] [Abstract][Full Text] [Related]
3. Neuronal degeneration in human diseases and animal models. Price DL; Martin LJ; Clatterbuck RE; Koliatsos VE; Sisodia SS; Walker LC; Cork LC J Neurobiol; 1992 Nov; 23(9):1277-94. PubMed ID: 1469388 [No Abstract] [Full Text] [Related]
4. New insights on the pathogenesis of neurodegenerative disorders. Piccoli F; La Bella V; Guarneri R Acta Neurol (Napoli); 1992; 14(4-6):455-68. PubMed ID: 1338180 [TBL] [Abstract][Full Text] [Related]
5. Neurodegenerative diseases and model systems. Price DL; Borchelt DR; Wong PC; Pardo CA; Thinakaran G; Lee MK; Cleveland DW; Sisodia SS Cold Spring Harb Symp Quant Biol; 1996; 61():725-38. PubMed ID: 9246498 [No Abstract] [Full Text] [Related]
6. Degenerative changes of neurocytes in the light of autoradiographic investigations. Kozik M Pathol Eur; 1971; 6(2):137-51. PubMed ID: 5142965 [No Abstract] [Full Text] [Related]
7. [Animal models in neurology: prospects and limitations]. Mix E; Meyer-Rienecker H; Zettl UK Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S14-20. PubMed ID: 19685384 [TBL] [Abstract][Full Text] [Related]
8. [The degenerative diseases of the nervous system from the neuropathological viewpoint]. Seitelberger F Wien Klin Wochenschr; 1968 Nov; 80(45):865-71. PubMed ID: 5708947 [No Abstract] [Full Text] [Related]
11. How trinucleotide repeats may function. Jennings C Nature; 1995 Nov; 378(6553):127. PubMed ID: 7477311 [No Abstract] [Full Text] [Related]
12. [Gene therapy of neurologic diseases. Experimental approaches and clinical perspectives]. Isenmann S; Bähr M; Dichgans J Nervenarzt; 1996 Feb; 67(2):91-108. PubMed ID: 8851291 [TBL] [Abstract][Full Text] [Related]
13. [Evolution of theories on diseases and degenerative processes in the nervous system]. Dambska M Neuropatol Pol; 1988; 26(1):1-8. PubMed ID: 3226548 [No Abstract] [Full Text] [Related]
14. [Neurodegenerative disorders and the role of trinucleotide repeat expansion. III. Molecular pathophysiology]. Kremer HP; Knoers NV Ned Tijdschr Geneeskd; 1996 Nov; 140(47):2333-6. PubMed ID: 8984396 [No Abstract] [Full Text] [Related]
15. Neurotrophic factor therapy for nervous system degenerative diseases. Hefti F J Neurobiol; 1994 Nov; 25(11):1418-35. PubMed ID: 7852995 [TBL] [Abstract][Full Text] [Related]
16. [Leber's disease and nervous-system-degeneration syndromes]. Bronner A; Gerhard JP; Collard M; Malamet S Rev Otoneuroophtalmol; 1979; 51(1):19-24. PubMed ID: 472584 [No Abstract] [Full Text] [Related]
18. Ultrastructural organization of GABA-like immunoreactive profiles in the weaver substantia nigra. Smith DE; Xu SG J Neurocytol; 2003 Mar; 32(3):293-303. PubMed ID: 14724391 [TBL] [Abstract][Full Text] [Related]
19. An ultrastructural study of methylmercury-induced primary sensory neuropathy in the rat. Herman SP; Klein R; Talley FA; Krigman MR Lab Invest; 1973 Jan; 28(1):104-18. PubMed ID: 4569929 [No Abstract] [Full Text] [Related]